|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
47,900,000 |
Market
Cap: |
53.65(M) |
Last
Volume: |
92,722 |
Avg
Vol: |
374,904 |
52
Week Range: |
$1.04 - $2.66 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P SMALLCAP 600 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Enzo Biochem is a diagnostics, clinical lab, and life sciences company. Co.'s operating segments include: Enzo Clinical Lab, which is a clinical reference laboratory providing a range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies; Enzo Life Sciences, which manufactures, develops and markets products and tools for clinical research, drug development and bioscience research customers worldwide; Enzo Therapeutics, which is a biopharmaceutical venture that has developed multiple approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases, various of which are derived from the work of Enzo Life Sciences.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
417,900 |
Total Buy Value |
$0 |
$0 |
$0 |
$873,769 |
Total People Bought |
0 |
0 |
0 |
5 |
Total Buy Transactions |
0 |
0 |
0 |
14 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Wolf James G. |
10% Owner |
|
2022-11-01 |
4 |
B |
$2.14 |
$18,225 |
I/I |
8,500 |
418,500 |
1.5 |
-54% |
|
Wolf James G. |
10% Owner |
|
2022-10-31 |
4 |
B |
$2.15 |
$31,175 |
I/I |
14,500 |
415,000 |
1.5 |
-51% |
|
Wolf James G. |
10% Owner |
|
2022-10-28 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
418,500 |
|
-51% |
|
Wolf James G. |
10% Owner |
|
2022-10-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,560,000 |
|
-51% |
|
Cannon Kara |
Chief Operating Officer |
|
2022-07-15 |
4 |
B |
$2.42 |
$6,050 |
D/D |
2,500 |
2,500 |
2.74 |
-18% |
|
Walters Ian B. |
Director |
|
2022-07-12 |
4 |
A |
$0.00 |
$0 |
D/D |
41,666 |
80,729 |
|
- |
|
Radoff Bradley Louis |
Director |
|
2022-07-12 |
4 |
A |
$0.00 |
$0 |
D/D |
41,666 |
4,236,329 |
|
- |
|
Tagliaferri Mary |
Director |
|
2022-07-12 |
4 |
A |
$0.00 |
$0 |
D/D |
41,666 |
80,729 |
|
- |
|
Radoff Bradley Louis |
Director |
|
2022-07-12 |
4 |
B |
$2.27 |
$28,375 |
D/D |
12,500 |
4,194,663 |
2.39 |
-18% |
|
Radoff Bradley Louis |
Director |
|
2022-07-05 |
4 |
B |
$2.20 |
$264,000 |
D/D |
120,000 |
4,182,163 |
2.39 |
5% |
|
Radoff Bradley Louis |
Director |
|
2022-06-16 |
4 |
B |
$2.20 |
$165,000 |
D/D |
75,000 |
4,062,163 |
2.39 |
-9% |
|
Radoff Bradley Louis |
Director |
|
2022-06-15 |
4 |
B |
$2.21 |
$110,500 |
D/D |
50,000 |
3,987,163 |
2.39 |
-2% |
|
Erfanian Hamid |
Chief Executive Officer |
|
2022-06-15 |
4 |
B |
$2.19 |
$10,074 |
D/D |
4,600 |
274,600 |
2.74 |
-2% |
|
Bench David |
Chief Financial Officer |
|
2022-06-14 |
4 |
B |
$2.15 |
$7,525 |
I/I |
3,500 |
6,000 |
1.99 |
6% |
|
Radoff Bradley Louis |
Director |
|
2022-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
39,063 |
3,937,163 |
|
- |
|
Walters Ian B. |
Director |
|
2022-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
39,063 |
39,063 |
|
- |
|
Tagliaferri Mary |
Director |
|
2022-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
39,063 |
39,063 |
|
- |
|
Bench David |
Chief Financial Officer |
|
2022-04-14 |
4 |
A |
$2.90 |
$4,698 |
I/I |
1,620 |
2,500 |
|
- |
|
Erfanian Hamid |
Chief Executive Officer |
|
2022-04-13 |
4 |
A |
$2.90 |
$29,000 |
D/D |
10,000 |
270,000 |
|
- |
|
Bench David |
Chief Financial Officer |
|
2022-04-13 |
4 |
A |
$2.90 |
$2,552 |
I/I |
880 |
880 |
|
- |
|
Cannon Kara |
Chief Operating OfficerOfficer |
|
2022-03-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
22,614 |
|
-16% |
|
Radoff Bradley Louis |
Director |
|
2022-01-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
400,000 |
|
-27% |
|
Radoff Bradley Louis |
Director |
|
2022-01-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,898,100 |
|
-27% |
|
Erfanian Hamid |
Chief Executive Officer |
|
2021-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
260,000 |
260,000 |
|
- |
|
Harbert Raymond J |
10% Owner |
|
2021-03-16 |
4 |
S |
$4.54 |
$1,393,900 |
I/I |
(300,000) |
5,175,913 |
|
25% |
|
264 Records found
|
|
Page 2 of 11 |
|
|